SuperworthDyadic International market cap DYAI
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $14.5M
- Highest close in our data
- $270.8M
- Jun 2020
Dyadic International is worth $14.5M at the close on Oct 23, 2026, at $0.40 a share.
That is down 65% over the last year and down 88% over five years.
Its highest close in our data was $270.8M in Jun 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $14.5M | $14.5M | $45.9M | −58% |
| 2025 | $34.4M | $27.1M | $54.4M | −41% |
| 2024 | $58M | $29.5M | $63.7M | +25% |
| 2023 | $46.4M | $35.7M | $67.7M | +32% |
| 2022 | $35.1M | $34.8M | $117.5M | −72% |
| 2021 | $126.9M | $92.3M | $186.6M | −14% |
| 2020 | $147.9M | $108.9M | $270.8M | +3% |
| 2019 | $143.7M | $86.6M | $179M | n/a |
Against its peers
Companies in Healthcare nearest Dyadic International's size, closest first, today.
| Company | Market cap |
|---|---|
| DYAIDyadic International | $14.5M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| ICCCImmucell | $93.1M |
| KEQUKewaunee Scientific | $94.9M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Dyadic International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.